Table 1 Patient demographics and interventions
Chemotherapy | No chemotherapy | |
|---|---|---|
No. of patients | 43 (40 %) | 61 (60 %) |
Mean age (yrs) (SD) | 64 (15) | 68 (12) |
Cancer primary | ||
Lung (Small cell) | 0 (0 %) | 1 (2 %) |
Lung (Non-small cell) | 17 (40 %) | 16 (26 %) |
Mesothelioma | 3 (7 %) | 9 (15 %) |
Breast | 11 (26 %) | 16 (26 %) |
Other | 12 (28 %) | 19 (31 %) |
Median duration IPC in-situ (days) (IQR) | 28 (14–58) | 69 (47–143) |
Median duration of concurrent chemotherapy (IQR) | 52 (21–105) (~4 cycles) | - |